Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $562,027 - $976,358
-65,352 Reduced 82.94%
13,442 $200,000
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $716,904 - $922,256
-73,079 Reduced 48.12%
78,794 $885,000
Q2 2023

Aug 14, 2023

SELL
$8.08 - $10.37 $507,852 - $651,785
-62,853 Reduced 29.27%
151,873 $1.53 Million
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $75,945 - $125,971
-8,640 Reduced 3.87%
214,726 $2.02 Million
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $413,490 - $491,222
-35,987 Reduced 13.88%
223,366 $2.73 Million
Q3 2022

Nov 14, 2022

SELL
$12.41 - $32.42 $1.3 Million - $3.41 Million
-105,029 Reduced 28.82%
259,353 $3.22 Million
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $1.01 Million - $1.37 Million
-51,650 Reduced 12.41%
364,382 $7.15 Million
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $6.6 Million - $7.77 Million
-267,920 Reduced 39.17%
416,032 $10.9 Million
Q4 2021

Feb 14, 2022

SELL
$27.74 - $34.09 $12.8 Million - $15.7 Million
-460,404 Reduced 40.23%
683,952 $19.4 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $323,302 - $406,563
-11,072 Reduced 0.96%
1,144,356 $36.5 Million
Q2 2021

Aug 16, 2021

SELL
$28.76 - $35.98 $3.2 Million - $4.01 Million
-111,407 Reduced 8.79%
1,155,428 $40.1 Million
Q1 2021

May 14, 2021

SELL
$27.85 - $34.49 $158,020 - $195,696
-5,674 Reduced 0.45%
1,266,835 $37.3 Million
Q4 2020

Feb 16, 2021

SELL
$27.53 - $33.79 $32,072 - $39,365
-1,165 Reduced 0.09%
1,272,509 $39 Million
Q3 2020

Nov 16, 2020

BUY
$21.1 - $29.13 $1.86 Million - $2.56 Million
87,917 Added 7.41%
1,273,674 $35.6 Million
Q2 2020

Aug 14, 2020

BUY
$18.94 - $24.93 $305,824 - $402,544
16,147 Added 1.38%
1,185,757 $25.4 Million
Q1 2020

May 15, 2020

BUY
$16.68 - $32.25 $785,461 - $1.52 Million
47,090 Added 4.2%
1,169,610 $26.2 Million
Q4 2019

Feb 14, 2020

BUY
$25.29 - $29.45 $6.28 Million - $7.31 Million
248,202 Added 28.39%
1,122,520 $33.1 Million
Q3 2019

Nov 14, 2019

BUY
$25.62 - $34.96 $6.55 Million - $8.94 Million
255,844 Added 41.37%
874,318 $23.2 Million
Q2 2019

Aug 14, 2019

BUY
$31.11 - $34.79 $9.16 Million - $10.2 Million
294,330 Added 90.8%
618,474 $20.9 Million
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $9.4 Million - $10.6 Million
324,144 New
324,144 $10.4 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.